West Pharmaceutical Services stock

WST · NYSE · USD

Compare West Pharmaceutical Services
$414.12Change from previous close: −0.88%Absolute change: −$3.68

Close · November 17, 2026

Price history

+58.02% over the period

1 year: from $262.41 (November 17, 2025) to $414.66 (November 17, 2026), +58.02%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026$414.66
October 30, 2026$412.62
September 30, 2026$370.76
August 31, 2026$341.11
July 31, 2026$340.96
June 30, 2026$359.00
May 29, 2026$322.81
April 30, 2026$297.59
March 31, 2026$250.64
February 27, 2026$254.34
January 30, 2026$231.12
December 31, 2025$275.14
November 28, 2025$277.25
November 17, 2025$262.41

At a glance

  • The company

    Design, manufacture and sell containment and delivery systems for injectable drugs and healthcare products globally

  • Latest results

    Quarter to September 30, 2026 · EPS $2.66 (estimate $2.20)

TickerLandia's take on West Pharmaceutical Services

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$223.83
52-wk high$438.27

−5.51% from the 52-week high

Analysts · 16 analysts

Average target$471.00+13.74% vs. price

Buy 15 · Hold 0 · Sell 1

TickerLandia Fingerprint: West Pharmaceutical Services

Compared with similar companies: very strong momentum and very high financial strength.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 17, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

West Pharmaceutical Services is pricier than in the past and pricier than similar companies

On the latest fiscal year's earnings (2025), West Pharmaceutical Services's P/E today is 61.1, above the median of its last 10 fiscal years (45.8; between 30.4 and 62.0 from 2016 to 2025). West Pharmaceutical Services's P/E (trailing 12 months): 46.9, +37% against the median of a group of 9 similar companies (34.3).

P/E compared with its history

Compared with 9 similar companies

West Pharmaceutical Services's metrics compared with similar companies
MetricWest Pharmaceutical ServicesPosition in the groupBand
P/E (trailing 12 months)46.9High
Forward P/E40.2High
Operating margin22.9%High
ROE21.2%High
Debt/equity0.11Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: West Pharmaceutical Services. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$874.5M

Latest quarter · Q3 2026

Net income

$214M

Latest quarter · Q3 2026

Quarterly net margin

24.5%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$29.1B
P/E
46.9
EPS
$8.91
Volume
525.77K
Daily trading
€284.48M
Dividend yield
0.22%
Last ex-dividend on November 10, 2026

How West Pharmaceutical Services is changing

All results
  • Revenue grew 7.4% a year on average over the last 5 years

  • Operating margin fell from 25.4% to 19.0%

  • Free cash flow equal to 73% of net income

Returns

West Pharmaceutical Services returns with dividends

$1,000 invested in West Pharmaceutical Services 5 years ago, on November 17, 2021, would be worth $945 today with dividends reinvested: −5.49% in total, −1.12% per year. On price alone it would be $933 (−6.75%).

PeriodWest Pharmaceutical ServicesS&P 500$1,000 becomes
1 month+8.01%−3.17%$1,080
6 months+36.72%+0.11%$1,367
Year to date+50.71%+8.34%$1,507
1 year+58.49%+11.15%$1,585
3 years+22.02%+64.30%$1,220
5 years−5.49%+58.18%$945
10 years+435.70%+239.10%$5,357

Over the last 6 months it has done better than 75% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

West Pharmaceutical Services: technical analysis

West Pharmaceutical Services is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 12.1% below its highest close since January 2, 1990 ($471.34, December 30, 2021).

Trend
Upward
RSI (14 sessions)
63
Between 30 and 70
vs 200-session average
+28.13%

Support and resistance

Price areas where West Pharmaceutical Services has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price$414.12
  3. Support$384.19−7.23%4 touches, last on November 6, 2026
  4. Support$359.48−13.19%3 touches, last on October 8, 2026
  5. Support$331.43−19.97%2 touches, last on September 10, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.63
Volatility (60 sessions, annualised)
22.9%
Largest fall in the last year
−18.77%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

West Pharmaceutical Services: seasonality

Average monthly price change over 37 years

−0.2%Jan−0.2%Feb+2.6%Mar+3.3%Apr+1.3%May+2.6%Jun+1.1%Jul+0.8%Aug+0.5%Sep−0.2%Oct+2.1%Nov+2.2%Dec

Over the last 37 years, the strongest month for West Pharmaceutical Services has been April: +3.27% on average, positive in 21 years out of 37. The weakest has been October: −0.24% on average, positive in 21 years out of 37. November, the current month, has been positive in 26 years out of 36 (+2.07% on average).

Show chart data
MonthAverageMedianPositive years
January−0.22%−0.40%16 of 36
February−0.24%+0.45%19 of 37
March+2.65%+2.24%24 of 37
April+3.27%+2.71%21 of 37
May+1.30%+1.11%21 of 37
June+2.58%+0.75%22 of 37
July+1.05%+0.32%20 of 37
August+0.82%+2.44%24 of 37
September+0.54%+0.83%21 of 37
October−0.24%+1.42%21 of 37
November+2.07%+2.27%26 of 36
December+2.25%+0.95%24 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

West Pharmaceutical Services and its competitors

Biologic, generic and pharmaceutical drug companies are the main customers for the packaging and delivery systems, while pharmaceutical, diagnostic and medical device companies order contract-manufactured devices. Sales reach the Americas, Europe, the Middle East, Africa and Asia Pacific through its sales force, contract sales agents and regional distributors. Product lines include stoppers and seals, syringe and cartridge parts, vials, self-injection devices and administration systems for reconstitution and mixing, along with inspection, sterilization and analytical lab services.

Headquarters
Exton, United States
Employees
10,000
Founded
1923
Chief executive
Michel Lagarde
West Pharmaceutical Services and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
West Pharmaceutical ServicesWST$29.1B22.9%46.9+36.72%
ResMedRMD$33.5B34.0%21.8+17.82%
MedlineMDLN$42.57B5.0%40.2+4.12%
Becton, DickinsonBDX$58.96B15.7%42.8+50.15%
SolventumSOLV$15.07B5.9%99.6+15.89%
Baxter InternationalBAX$13.41B7.6%—+48.90%

Same industry or related industries, similar size. Compare West Pharmaceutical Services with its competitors · Full profile